# Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma

> **NCT02489838** · — · COMPLETED · sponsor: **Alan Katz** · enrollment: 56 (actual)

## Conditions studied

- Liver Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02489838
- **Lead sponsor:** Alan Katz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-03
- **Primary completion:** 2019-08-07
- **Final completion:** 2019-08-07
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02489838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02489838, "Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02489838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*